BVBiomed Ltd. Presents at ECTRIMS 2015
BVBiomed Ltd. presented the latest work on relaxin in the animal model of multiple sclerosis EAE. The positive results in this study support relaxin as a potential new treatment of multiple sclerosis.
Featured Posts
Recent Posts
